1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LUCY SCIENTIFIC DISCOVERY INC
Lucy Scientific Discovery Inc XNAS: LSDIF


Insider Trading disclosures for Lucy Scientific Discovery Inc

The latest disclosure was made by Livio Susin in Lucy Scientific Discovery Inc where a trade of 9,309 Common Shares done at an average price of $2.4 was reported to US exchanges on Feb. 13, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Livio Susin Director Other type of transaction at price $ 2.40 per share. 13 Feb 2023 9,309 134,809 - 2.4 22,342 Common Shares
Assad J. Kazeminy Chief Scientific Officer Other type of transaction at price $ 2.40 per share. 13 Feb 2023 85,000 85,000 - 2.4 204,000 Common Shares
Christopher McElvany Director, President and CEO 13 Feb 2023 500,000 0 - - 8% Convertible Promissory Note
Christopher McElvany Director, President and CEO Other type of transaction at price $ 2.40 per share. 13 Feb 2023 118,403 118,403 - 2.4 284,167 Common Shares
Christopher McElvany Director, President and CEO 13 Feb 2023 366,187 366,187 - 2.4 878,849 Common Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures